Pearl Therapeutics Receives $18,000,000 Series A Financing Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=55787a45-688f-47b3-b525-dcdfe1e466bd&Preview=1 -
Date
7/3/2008 -
Company Name
Pearl Therapeutics -
Mailing Address
200 Saginaw Drive Redwood City, CA 94063 -
Company Description
Pearl Therapeutics is focused on developing a pipeline of novel and
superior products for chronic respiratory disorders, providing patients
with advanced therapeutic options in familiar and well accepted dosage
forms. The company has licensed advanced particle technology from Nektar
Therapeutics (Nasdaq: NKTR) for developing a series of products in selected
therapeutic fields. -
Website
http://www.pearltherapeutics.com -
Transaction Type
Venture Equity -
Transaction Amount
$18,000,000 -
Transaction Round
Series A -
Proceeds Purposes
This additional capital will allow us to broaden and progress development efforts on our products and delivery platform,” said Adrian Smith, President, and co-founder of Pearl. -
M&A Terms
-
Venture Investor
Clarus Ventures -
Venture Investor
New Leaf Venture Partners -
Venture Investor
5AM Ventures
